Results 131 to 140 of about 1,314 (191)

Incident glaucoma and ocular hypertension after periocular and intravitreal steroid injections: a claims-based analysis. [PDF]

BMJ Open Ophthalmol, 2023
Polski A, Liu KC, Gupta D, Grewal DS, Horns J, Wirostko BM, Stagg BC.   +6 more
europepmc   +1 more source

Pathogenesis and current therapies for non-infectious uveitis. [PDF]

Clin Exp Med, 2023
Wu X, Tao M, Zhu L, Zhang T, Zhang M.
europepmc   +1 more source

Inflammatory mechanisms in diabetic retinopathy: pathogenic roles and therapeutic perspectives. [PDF]

Am J Transl Res
Qian HY, Wei XH, Huang JO.
europepmc   +1 more source

Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve. [PDF]

J Ocul Pharmacol Ther, 2023
Kessler LJ, Auffarth GU, Khoramnia R.
europepmc   +1 more source

Estimation of Value-Based Price for 48 High-Technology Medical Devices. [PDF]

Cureus, 2023
Hyeraci G, Trippoli S, Rivano M, Messori A.   +3 more
europepmc   +1 more source

Causes of Visual Loss in Uveitis: A Retrospective Study at a Tertiary Referral Centre. [PDF]

Cureus
Al-Roubaie M, Beare N.
europepmc   +1 more source

Back of the Eye Drug Delivery: Advances, Challenges, and Emerging Opportunities for Transformative Therapies. [PDF]

J Ocul Pharmacol Ther
Chauhan A, Kompella U.
europepmc   +1 more source

Basic Research and Clinical Application of Drug Delivery Systems for the Treatment of Age-Related Macular Degeneration [PDF]

, 2012
Alessandro Galan, Giuseppe Lo Giudice
core   +1 more source

Pentraxin-3 and Lipocalin-2 are decreased in patients with uveal effusion syndrome. [PDF]

Int Ophthalmol
Havertz C, Schworm B, Siedlecki J, Wilfert W, Northoff B, Priglinger SG, Keidel LF.   +6 more
europepmc   +1 more source

Fluocinolone Acetonide Implant Removal From the Vitreous Cavity. [PDF]

J Vitreoretin Dis, 2023
Valikodath N, Vajzovic L.
europepmc   +1 more source